6533b7dafe1ef96bd126eca1
RESEARCH PRODUCT
Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors.
Marta SuñerMariaconcetta RussoSaskia MiddeldorpHessel Peters-sengersFrederike J. BemelmanAurora Solier-lopezLuis Jara-palomaresFrancisco M González-ronceroBarco Stefanosubject
Oncologymedicine.medical_specialtymTORiPatient risk2720 HematologyMEDLINE610 Medicine & healthStratification (mathematics)Internal medicinemedicineHumansEverolimusSirolimusEverolimusHematologybusiness.industry10031 Clinic for AngiologyTOR Serine-Threonine KinasesAnticoagulantsHematologyVenous ThromboembolismDiscovery and development of mTOR inhibitorsKidney TransplantationTransplantationRenal transplantSirolimusbusinessImmunosuppressive AgentsVenous thromboembolismmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2020-11-01 | Thrombosis research |